{
    "ticker": "IFRX",
    "name": "ImmunoPrecise Antibodies Ltd.",
    "description": "ImmunoPrecise Antibodies Ltd. is a biopharmaceutical company dedicated to the development of innovative antibody-based therapies for the treatment of various diseases, including cancer and autoimmune disorders. Founded in 2011 and headquartered in Victoria, British Columbia, Canada, the company leverages its proprietary technology platforms to create monoclonal antibodies and other therapeutic agents. ImmunoPrecise utilizes advanced techniques in immunology, molecular biology, and protein engineering to develop high-quality antibodies that meet the growing needs of the pharmaceutical industry. The company's services encompass the entire process from antibody discovery to development, including humanization and optimization. ImmunoPrecise has established strong collaborations with biotech and pharmaceutical companies, enhancing its ability to innovate and deliver cutting-edge solutions. As the demand for effective biotherapeutics continues to rise, ImmunoPrecise is committed to advancing healthcare by providing transformative therapies and contributing to the growing field of personalized medicine.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Victoria, British Columbia, Canada",
    "founded": "2011",
    "website": "https://www.immunoprecise.com",
    "ceo": "ImmunoPrecise does not publicly list its CEO on its website.",
    "social_media": {
        "twitter": "https://twitter.com/immunoprecise",
        "linkedin": "https://www.linkedin.com/company/immunoprecise-antibodies-ltd"
    },
    "investor_relations": "https://www.immunoprecise.com/investor-relations",
    "key_executives": [
        {
            "name": "ImmunoPrecise does not publicly list its executives on its website.",
            "position": "CEO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutic Antibodies",
            "products": [
                "Monoclonal Antibodies",
                "Bispecific Antibodies"
            ]
        },
        {
            "category": "Antibody Development Services",
            "products": [
                "Antibody Discovery",
                "Humanization Services"
            ]
        }
    ],
    "seo": {
        "meta_title": "ImmunoPrecise Antibodies Ltd. | Innovative Antibody Therapies",
        "meta_description": "Explore ImmunoPrecise Antibodies Ltd., a biopharmaceutical company specializing in innovative antibody-based therapies. Learn about their commitment to advancing healthcare.",
        "keywords": [
            "ImmunoPrecise",
            "Antibodies",
            "Biopharmaceuticals",
            "Monoclonal Antibodies",
            "Cancer Treatment"
        ]
    },
    "faq": [
        {
            "question": "What does ImmunoPrecise specialize in?",
            "answer": "ImmunoPrecise specializes in the development of innovative antibody-based therapies for various diseases."
        },
        {
            "question": "Where is ImmunoPrecise headquartered?",
            "answer": "ImmunoPrecise is headquartered in Victoria, British Columbia, Canada."
        },
        {
            "question": "When was ImmunoPrecise founded?",
            "answer": "ImmunoPrecise was founded in 2011."
        }
    ],
    "competitors": [
        "ABBV",
        "AMGN",
        "REGN",
        "SNY"
    ],
    "related_stocks": [
        "GILD",
        "VRTX",
        "BMY",
        "MRNA"
    ]
}